N | Group A | Group B | T or X2 | P |
---|---|---|---|---|
30 | 30 | |||
Follow-up period (month) | 10.7 ± 2.1 | 9.7 ± 2.9 | T = 1.524 | P = 0.133 |
Complications | X2 = 2.308 | P = 0.129 | ||
Infection | 1 | 2 | ||
Necrosis | 1 | 4 | ||
TAM score at one month follow | X2 = 6.933 | P = 0.031* | ||
Excellent | 10 | 20 | ||
Good | 14 | 6 | ||
Poor | 6 | 4 | ||
TAM score at last follow | X2 = 0.132 | P = 0.936 | ||
Excellent | 25 | 24 | ||
Good | 4 | 5 | ||
Poor | 1 | 1 | ||
2-PD (mm) | 4.43 ± 1.2 | 5.5 ± 1.8 | T = 2.71 | P = 0.009* |
Vancouver scale (Reconstructed site) | 4.13 ± 0.3 | 3.92 ± 0.5 | T = 2.138 | P = 0.037* |
Vancouver scale (Donor site) | 4.0 ± 0.4 | 3.20 ± 0.3 | T = 9.012 | P = 0.001* |